(Q43169185)

English

Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database

scientific article published in December 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 November 2017

Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database (English)

1 reference

Europe PubMed Central

15 November 2017

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

15 November 2017

9

1 reference

Europe PubMed Central

15 November 2017

Maja Beck Popovic

2

object named as

Maja Beck-Popovic

1 reference

Europe PubMed Central

15 November 2017

author name string

Rochelle Bagatell

1

1 reference

Europe PubMed Central

15 November 2017

Wendy B London

3

1 reference

Europe PubMed Central

15 November 2017

Yang Zhang

4

1 reference

Europe PubMed Central

15 November 2017

Andrew D J Pearson

5

1 reference

Europe PubMed Central

15 November 2017

Katherine K Matthay

6

1 reference

Europe PubMed Central

15 November 2017

Tom Monclair

7

1 reference

Europe PubMed Central

15 November 2017

International Neuroblastoma Risk Group

10

1 reference

Europe PubMed Central

15 November 2017

language of work or name

0 references

publication date

1 December 2008

1 reference

Europe PubMed Central

15 November 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

15 November 2017

27

1 reference

Europe PubMed Central

15 November 2017

3

1 reference

Europe PubMed Central

15 November 2017

365-370

1 reference

Europe PubMed Central

15 November 2017

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651034

25 May 2018

Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651034

25 May 2018

Chromosome 1p and 11q deletions and outcome in neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651034

25 May 2018

Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651034

25 May 2018

Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651034

25 May 2018

The International Neuroblastoma Pathology Classification (the Shimada system).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651034

25 May 2018

The International Neuroblastoma Risk Groups (INRG): a preliminary report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651034

25 May 2018

Successful management of low-stage neuroblastoma without adjuvant therapies: a comparison of two decades, 1972 through 1981 and 1982 through 1992, in a single institution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651034

25 May 2018

International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651034

25 May 2018

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651034

25 May 2018

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651034

25 May 2018

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651034

25 May 2018

Quality assessment of genetic markers used for therapy stratification.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651034

15 August 2018

Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651034

15 August 2018

Detection of N-myc gene amplification by fluorescence in situ hybridization. Diagnostic utility for neuroblastoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651034

15 August 2018

Neuroblastoma study NBL 79 of the German Society for Pediatric Oncology. Report after 2 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/19047282

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of human neuroblastoma cell lines that lack N-myc gene amplification

1 reference

https://pubmed.ncbi.nlm.nih.gov/19047282

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19047282

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss of the putative tumor suppressor-gene locus 1p36 as investigated by a PCR-assay and N-myc amplification in 48 neuroblastomas: results of the German Neuroblastoma Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19047282

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19047282

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2008.17.9184

1 reference

Europe PubMed Central

15 November 2017

1 reference

Europe PubMed Central

15 November 2017

1 reference

Europe PubMed Central

15 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43169185&oldid=1982797636"